AMPHIPATISCHES PEPTID
European patent · EP2928909 · In force
Register entry
- Publication number
- EP2928909
- Application number
- EP13805332
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Dec 9, 2013
- Published
- Oct 14, 2015
- Granted
- Aug 1, 2018
- Protection ends at the latest
- Dec 8, 2033
- Next annual fee due
- Dec 31, 2026
- IPC classes
- C07K 14/00 (2006.01)A61K 48/00 (2006.01)
- Priority
- GB 201222041 07.12.2012
- PCT application
- PCT/EP2013/075985 09.12.2013
- PCT publication
- WO2014/087023 12.06.2014
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 1, 2026
Change
Published in Swissreg on 01.01.2026
- Jun 6, 2025
Change
Published in Swissreg on 06.06.2025
- Jan 1, 2024
Change
Published in Swissreg on 01.01.2024
- Jan 1, 2023
Change
Published in Swissreg on 01.01.2023
- May 16, 2022
Address changed
- Representative
- RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich → RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich
Published in Swissreg on 16.05.2022
- Dec 17, 2021
Transferred
- Owner
- The Queen's University Of Belfast, University Road, Belfast, Antrim BT7 1NN, United Kingdom → pHion Therapeutics Ltd., 63 University Road, Belfast, Antrim BT7 1NN, United Kingdom
Published in Swissreg on 17.12.2021
- Oct 27, 2018
Agent entered
- Representative
- RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich
Published in Swissreg on 27.10.2018
- Aug 1, 2018
Granted
Published in Swissreg on 01.08.2018
Parties
Inventor
Belfast Antrim BT9 7BL, GB
Larchwood Staffordshire ST5 5BB, GB
Belfast Antrim BT7 3GB, GB
Belfast Antrim BT9 7BL, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.